Fortem Financial Group LLC Decreases Stock Holdings in Eli Lilly …

Jan 6, 2025 · Fortem Financial Group LLC reduced its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent 13F …

CouponFollow Extension

6%
OFF

Fortem Financial Group LLC Decreases Stock Holdings In Eli Lilly …

2 weeks from now

Jan 6, 2025 · Fortem Financial Group LLC reduced its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent 13F …

mayfieldrecorder.com

6%
OFF

Fortem Financial Group LLC Decreases Stock Holdings In Eli Lilly …

2 weeks from now

Jul 8, 2024 · Fortem Financial Group LLC trimmed its stake in shares of Eli Lilly and Company ( NYSE:LLY – Free Report) by 2.6% in the 1st quarter, Holdings Channel reports. The firm …

americanbankingnews.com

19%
OFF

Fortem Financial Group 13F Filings And Top Holdings And Stakes

2 weeks from now

Latest statistics and disclosures from Fortem Financial Group's latest quarterly 13F-HR filing: Top 5 stock holdings are AMJ , XLB , AAPL , XME , COWZ , and represent 17.19% of Fortem …

stockzoa.com

$432167981
OFF

FORTEM FINANCIAL GROUP, LLC Top 13F Holdings

2 weeks from now

Fortem Financial Group is based out of Palm Desert. Fortem Financial Group is a large advisory firm with 300 clients and discretionary assets under management (AUM) of $432,167,981 …

whalewisdom.com

$2050000
OFF

BTC Capital Management Inc. Decreases Position In Eli Lilly And …

2 weeks from now

5 days ago · Cooper Financial Group now owns 2,655 shares of the company's stock worth $2,050,000 after buying an additional 695 shares during the period. Everence Capital …

marketbeat.com

9%
OFF

Range Financial Group LLC Acquires 3,744 Shares Of Eli Lilly And ...

2 weeks from now

Jan 7, 2025 · Range Financial Group LLC increased its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 476.9% during the fourth quarter, according to its …

marketbeat.com

3%
OFF

Fortem Financial Group LLC Has $368,000 Stake In Uber …

2 weeks from now

Jan 7, 2025 · Fortem Financial Group LLC grew its holdings in Uber Technologies, Inc. (NYSE:UBER – Free Report) by 21.3% during the fourth quarter, according to the company in …

etfdailynews.com

$147.78
OFF

Fortem Financial Group, Llc Buys Technology Select Sector SPDR …

2 weeks from now

Fortem Financial Group, Llc initiated holding in Technology Select Sector SPDR ETF. The purchase prices were between $147.78 and $176.65, with an estimated average price of …

yahoo.com

2%
OFF

Fiduciary Financial Group LLC Increases Holdings In Eli Lilly And ...

2 weeks from now

Jan 16, 2025 · Fiduciary Financial Group LLC increased its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 89.2% during the 4th quarter, according to its most recent …

marketbeat.com

80%
OFF

Press Release: Bergen Logistics Acquired By The Elanders Group

2 weeks from now

Nov 11, 2021 · The Elanders group has acquired an 80% ownership interest in Bergen; founder Ron Roman maintains a 20% stake in the company and will be CEO of the company. This …

bergenlogistics.com

FAQs about Fortem Financial Group LLC Decreases Stock Holdings in Eli Lilly … Coupon?

Does fortem Financial Group LLC own Uber Technologies?

Fortem Financial Group LLC’s holdings in Uber Technologies were worth $368,000 as of its most recent filing with the SEC. Several other large investors also recently made changes to their positions in UBER. GHP Investment Advisors Inc. raised its position in Uber Technologies by 222.7% in the 2nd quarter. ...

How did Eli Lilly & Company (LLY) perform in 2024?

The one-month return of Eli Lilly and Company (NYSE:LLY) was 6.98%, and its shares gained 14.48% of their value over the last 52 weeks. On February 5, 2024, Eli Lilly and Company (NYSE:LLY) stock closed at $842.18 per share, with a market capitalization of $757.386 billion. ...

Is Eli Lilly a pharma company?

"Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical company with core franchises in diabetes, obesity, neurology, and oncology. Its portfolio includes innovative drugs like Mounjaro, Zepbound, Trulicity, Jardiance (diabetes and obesity), Taltz (psoriasis), Emgality (migraines), and Verzenio (breast cancer). ...